Approval No: SFDA approval number H20213592
Specification: 23.75mg
Packaging/box: 14 tablets&28 tablets
Production enterprise: Hefei Heyuan Pharmaceutical Co., LTD
Mass stratification: New Category 4 (Consistent overassessment)
Medical insurance: Medical insurance class B
Adapt to disease:
Hypertension, angina, chronic heart failure